AngioVac-assisted management of histoplasma capsulatum endocarditis in a bioprosthetic aortic valve: challenges and

Qutaiba Qafisheh1, Abdalhakim Shubietah2, Roaa Aljunaidi3

  • 1Department of Internal Medicine, University of Toledo, Toledo, USA.

PubMed
Abstract

Insights

Histoplasma capsulatum infective endocarditis (IE) is rare. AngioVac aided in managing large fungal vegetations in a prosthetic valve patient, highlighting the need for considering fungal IE in culture-negative cases.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Medical Device Technology

Background:

  • Histoplasma capsulatum infective endocarditis (IE) is a rare but often fatal condition.
  • Prosthetic valve patients are at high risk due to diagnostic delays and limited treatment options.
  • Fungal IE should be considered in culture-negative cases, particularly in high-risk individuals.

Purpose of the Study:

  • To report a case of Histoplasma capsulatum infective endocarditis in a prosthetic valve patient.
  • To demonstrate the utility of the AngioVac system for managing large fungal vegetations.
  • To emphasize the importance of a multidisciplinary approach in managing complex IE cases.

Main Methods:

  • A 76-year-old female with a bioprosthetic aortic valve presented with persistent culture-negative fever and splenic infarcts.
  • AngioVac-assisted debulking was performed for large vegetations on the prosthetic valve.
  • Tissue cultures obtained during debulking confirmed Histoplasma capsulatum.

Main Results:

  • AngioVac facilitated the removal of large fungal vegetations, enabling diagnosis of Histoplasma capsulatum.
  • Despite prompt antifungal therapy and multidisciplinary management, the patient experienced recurrent embolic events and septic shock.
  • The patient ultimately succumbed to the infection.

Conclusions:

  • This case highlights the critical need to consider fungal IE in culture-negative endocarditis, especially in patients with prosthetic valves.
  • Advanced diagnostic tools and minimally invasive interventions like AngioVac can play a role in managing complex fungal IE.
  • Despite interventions, the management of severe fungal IE remains challenging, underscoring the need for early diagnosis and comprehensive care.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...